ConforMIS Inc. (NASDAQ:CFMS) shot up 4% on Thursday . The company traded as high as $7.38 and last traded at $7.26, with a volume of 138,588 shares changing hands. The stock had previously closed at $6.98.

A number of brokerages have recently weighed in on CFMS. Zacks Investment Research upgraded shares of ConforMIS from a “sell” rating to a “hold” rating in a report on Friday, July 1st. Oppenheimer Holdings Inc. restated an “outperform” rating and issued a $12.00 price objective (down from $18.00) on shares of ConforMIS in a report on Tuesday, May 17th. Canaccord Genuity restated a “buy” rating on shares of ConforMIS in a report on Saturday, May 14th. Deutsche Bank AG reduced their price objective on shares of ConforMIS from $26.00 to $12.00 and set a “buy” rating on the stock in a report on Friday, May 13th. Finally, Wells Fargo & Co. lowered shares of ConforMIS from an “outperform” rating to a “market perform” rating in a report on Friday, May 13th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $15.20.

The company’s market cap is $319.28 million. The company has a 50 day moving average of $7.20 and a 200 day moving average of $10.28.

ConforMIS (NASDAQ:CFMS) last released its quarterly earnings data on Thursday, May 12th. The company reported ($0.37) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.38) by $0.01. The business had revenue of $20.30 million for the quarter, compared to analysts’ expectations of $19.23 million. The company’s quarterly revenue was up 38.1% compared to the same quarter last year. Equities research analysts predict that ConforMIS Inc. will post ($1.38) earnings per share for the current fiscal year.

A hedge fund recently raised its stake in ConforMIS stock. Wells Fargo & Company MN raised its stake in ConforMIS Inc. (NASDAQ:CFMS) by 38.7% during the fourth quarter, Holdings Channel reports. The institutional investor owned 501,056 shares of the company’s stock after buying an additional 139,708 shares during the period. Wells Fargo & Company MN owned about 1.23% of ConforMIS worth $8,663,000 at the end of the most recent quarter.

ConforMIS, Inc is a medical technology company that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants. The Company’s products include iTotal CR, which is the cruciate-retaining, customized total knee replacement system to restore the natural shape of a patient’s knee; iTotal PS, which is the posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product to restore the natural shape of a patient’s knee; iDuo, which is the customized bicompartmental knee replacement system, and iUni, which is the customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.